A detailed history of Five Oceans Advisors transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Five Oceans Advisors holds 10,372 shares of TEVA stock, worth $263,552. This represents 0.09% of its overall portfolio holdings.

Number of Shares
10,372
Previous 10,297 0.73%
Holding current value
$263,552
Previous $172,000 21.51%
% of portfolio
0.09%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

BUY
$15.38 - $20.2 $1,153 - $1,515
75 Added 0.73%
10,372 $209,000
Q2 2025

Jul 16, 2025

BUY
$12.82 - $18.15 $132,007 - $186,890
10,297 New
10,297 $172,000
Q4 2024

Jan 24, 2025

SELL
$16.43 - $22.77 $23,938 - $33,175
-1,457 Reduced 10.07%
13,018 $286,000
Q3 2024

Oct 15, 2024

BUY
$15.81 - $18.96 $60,710 - $72,806
3,840 Added 36.11%
14,475 $260,000
Q2 2024

Jul 10, 2024

BUY
$12.78 - $17.4 $135,915 - $185,048
10,635 New
10,635 $172,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $28.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Five Oceans Advisors Portfolio

Follow Five Oceans Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Five Oceans Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Five Oceans Advisors with notifications on news.